25B-NBOMe Dosage Guide

fatal at heavy dosages. 25B-NBOMe has been used in clinical trials with an evaluation dose for safety consideration to humans of only 1 microgram; Such a dose is 300× lower than the dose expected to be hallucinogenic to humans and it is expected that recreational use would greatly exceed doses determined to be safe to humans. It is strongly recommended that one use harm reduction practices when using this substance. 25B-not habit-forming, and the desire to use it can actually decrease with use. It is most often self-regulating. Tolerance to the effects of 25B-almost immediately after ingestion. After that,12 weeks to be back at baseline (in the absence of further consumption). 25B-NBOMe presents cross-tolerance with Cross-all psychedelics, meaning that after the consumption of 25B-NBOMe all psychedelics will have a reduced effect. - Overdose - **Austria:** Since June 26, 2019, 25B-NBOMe is illegal to possess, produce and sell under the SMG. (Suchtmittelgesetz Österreich) - **Brazil:** Possession, production and sale is illegal as it is listed on Portaria SVS/MS nº 344. - **Canada:** 25B-NBOMe would be considered Schedule III as it is a derivative of 2,5-dimethoxyphenethylamine. - **China:** As of October 2015, 25B-NBOMe is a controlled substance in China. - **Germany:** 25B-NBOMe is controlled under Anlage I BtMG (Narcotics Act, Schedule I) as of December 13, 2014. It is illegal to manufacture, possess, import, export, buy, sell, procure or dispense it without a license. - **Italy:** 25B-NBOMe is a Schedule 1 controlled substance in Italy. - **Japan:** 25B-NBOMe is a narcotic drug in Japan effective November 1st, 2015. - **Latvia:** 25B-NBOMe is a Schedule I controlled substance. - **New Zealand:** 25B-NBOMe is a